AXCELLA HEALTH INC (AXLA)
US05454B2043 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to AXLA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 15870.09. This target is 346408.54% above the current price.
AXLA was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about AXLA.
In the previous month the buy percentage consensus was at a similar level.
AXLA was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-02-16 | HC Wainwright & Co. | Maintains | Neutral |
| 2022-12-16 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-12-15 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-11-02 | Chardan Capital | Maintains | Buy |
| 2022-10-03 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-03 | SVB Leerink | Maintains | Outperform |
| 2022-08-03 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-09 | Chardan Capital | Maintains | Buy |
| 2021-11-16 | Chardan Capital | Maintains | Buy |
| 2021-10-12 | Noble Capital Markets | Initiate | Outperform |
| 2021-09-22 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2021-07-30 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2021-07-06 | HC Wainwright & Co. | Initiate | Buy |
| 2021-06-03 | Chardan Capital | Maintains | Buy |